|
US2002049240A1
|
|
Novel compounds
|
|
EG22332A
|
|
Novel compounds
|
|
US6709859B1
|
|
Chromosomal DNA Fragments Encoding Enzymes for Encoding B-Lactam Biosynthesis Enzymes, and Vector and Transformants for Their Expression
|
|
US6037156A
|
|
DNA molecules and vectors encoding clavulanic acid biosynthesis enzymes
|
|
US6258555B1
|
|
DNA encoding ACV synthetase
|
|
KR0164275B1
|
|
Substituted thiazolidine dion derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
|
|
US5679789A
|
|
Pharmaceutical compositions comprising potassium clavulanate and methods of using them
|
|
US5674869A
|
|
Pharmaceutical treatment
|
|
US5646169A
|
|
Compounds for treating eating disorders in which blood glucose levels are raised
|
|
US5670170A
|
|
Pharamaceutical formulation
|
|
HU210801A9
|
|
Azabicyclo oxime compounds
|
|
US6288095B1
|
|
Compounds
|
|
US5814337A
|
|
Pharmaceutical formulation
|
|
DK74594A
|
|
Process for preparing paroxetine or a pharmaceutically acceptable salt thereof
|
|
US5684153A
|
|
Process for the preparation of purine derivatives
|
|
CA1339902C
|
|
Novel intermediates for preparing substitudes thiazolidinedione derivatives
|
|
SG116193G
|
|
Purine derivatives and their pharmaceutical use
|
|
SG114493G
|
|
Antiviral guanine derivatives
|
|
US5288861A
|
|
Potassium clavulanate in rosette form
|
|
US5322951A
|
|
Certain 1-(2,3-dihydro-indole)carbonyl intermediates
|
